201 related articles for article (PubMed ID: 33194049)
1. Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer.
Peng YL; Wu ZS; Lu HM; Wei WS; Xiong LB; Yu CP; Liu ZF; Li XD; Jiang LJ; Li YH; Liu ZW; Zhang ZL; Zhou FJ
Am J Transl Res; 2020; 12(10):6524-6536. PubMed ID: 33194049
[TBL] [Abstract][Full Text] [Related]
2. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
[No Abstract] [Full Text] [Related]
3. A TP53-based immune prognostic model for muscle-invasive bladder cancer.
Li H; Lu H; Cui W; Huang Y; Jin X
Aging (Albany NY); 2020 Dec; 13(2):1929-1946. PubMed ID: 33323544
[TBL] [Abstract][Full Text] [Related]
4. The landscape and prognostic value of tumor-infiltrating immune cells in gastric cancer.
Li L; Ouyang Y; Wang W; Hou D; Zhu Y
PeerJ; 2019; 7():e7993. PubMed ID: 31844561
[TBL] [Abstract][Full Text] [Related]
5. An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle-invasive bladder cancer (MIBC).
Jiang W; Zhu D; Wang C; Zhu Y
Cancer Med; 2020 Apr; 9(8):2774-2790. PubMed ID: 32096345
[TBL] [Abstract][Full Text] [Related]
6. Construction and Validation of an Immune-Related Prognostic Model Based on TP53 Status in Colorectal Cancer.
Zhao X; Liu J; Liu S; Yang F; Chen E
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31689990
[TBL] [Abstract][Full Text] [Related]
7. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer.
Zheng Z; Mao S; Zhang W; Liu J; Li C; Wang R; Yao X
Front Oncol; 2020; 10():542492. PubMed ID: 33392066
[TBL] [Abstract][Full Text] [Related]
9. An innovative risk index based on neutrophils and macrophages can effectively predict prognosis and immunotherapy response in patients with muscle-invasive bladder cancer.
Zhang X; Zhang A; Hu L; Xiong W; Shang P
Transl Cancer Res; 2023 Mar; 12(3):536-549. PubMed ID: 37033357
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles for a prognostic immunoscore in gastric cancer.
Zeng D; Zhou R; Yu Y; Luo Y; Zhang J; Sun H; Bin J; Liao Y; Rao J; Zhang Y; Liao W
Br J Surg; 2018 Sep; 105(10):1338-1348. PubMed ID: 29691839
[TBL] [Abstract][Full Text] [Related]
11. Significance of Tumor-Infiltrating Immune Cells in the Prognosis of Colon Cancer.
Wu D; Ding Y; Wang T; Cui P; Huang L; Min Z; Xu M
Onco Targets Ther; 2020; 13():4581-4589. PubMed ID: 32547088
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer.
Ye L; Zhang T; Kang Z; Guo G; Sun Y; Lin K; Huang Q; Shi X; Ni Z; Ding N; Zhao KN; Chang W; Wang J; Lin F; Xue X
Front Immunol; 2019; 10():2368. PubMed ID: 31681276
[TBL] [Abstract][Full Text] [Related]
13. Characterization of hazard infiltrating immune cells and relative risk genes in bladder urothelial carcinoma.
Lv Y; Jin P; Chen Z; Zhang P
Am J Transl Res; 2020; 12(11):7510-7527. PubMed ID: 33312386
[TBL] [Abstract][Full Text] [Related]
14. Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer.
Zhang S; Wang C; Xia W; Duan H; Qian S; Shen H
Int J Gen Med; 2021; 14():8651-8666. PubMed ID: 34849009
[TBL] [Abstract][Full Text] [Related]
15. A model based on tumor-infiltrating immune cells for predicting the relapse rates of patients with testicular germ cell tumors.
Wang Y; Ji C; Liu J; Wang Y; Song N; Cao P
Int Immunopharmacol; 2020 Sep; 86():106710. PubMed ID: 32652500
[TBL] [Abstract][Full Text] [Related]
16. Identification and Immunocorrelation of Prognosis-Related Genes Associated With Development of Muscle-Invasive Bladder Cancer.
Li J; Lou Y; Li S; Sheng F; Liu S; Du E; Zhang Z
Front Mol Biosci; 2020; 7():598599. PubMed ID: 33604353
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer.
Fu H; Zhu Y; Wang Y; Liu Z; Zhang J; Xie H; Fu Q; Dai B; Ye D; Xu J
Clin Cancer Res; 2018 Jul; 24(13):3069-3078. PubMed ID: 29514839
[No Abstract] [Full Text] [Related]
18. LCK and CD3E Orchestrate the Tumor Microenvironment and Promote Immunotherapy Response and Survival of Muscle-Invasive Bladder Cancer Patients.
Zheng X; Liao X; Nie L; Lin T; Xu H; Yang L; Shen B; Qiu S; Ai J; Wei Q
Front Cell Dev Biol; 2021; 9():748280. PubMed ID: 35004669
[No Abstract] [Full Text] [Related]
19. Comprehensive Analysis of Tumor-Infiltrating Immune Cells and Relevant Therapeutic Strategy in Esophageal Cancer.
Lu G; Chen L; Wu S; Feng Y; Lin T
Dis Markers; 2020; 2020():8974793. PubMed ID: 32454908
[TBL] [Abstract][Full Text] [Related]
20. Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy.
Yu A; Mansure JJ; Solanki S; Siemens DR; Koti M; Dias ABT; Burnier MM; Brimo F; Kassouf W
PLoS One; 2018; 13(10):e0205746. PubMed ID: 30308033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
